secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2025-12-05T23:59:59+00:00
Accession:  0001829126-25-009747
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO raises $10M in registered direct offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Sold 900K shares and pre-funded warrants for 9.1M shares at $1.00 per share (warrants at $0.9999).
- Gross proceeds of $10M; net proceeds to be used to repay indebtedness and for general corporate purposes.
- Offering closed on December 5, 2025; H.C. Wainwright & Co. acted as exclusive placement agent.
- Placement agent fee of 8.0% of gross proceeds plus $50K legal and $15,950 clearing expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/0001829126-25-009747-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000182912625009747/kalabio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-009747

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer